Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Boosting hope, study finds Oxford virus vaccine builds strong immunity

Bristol University study has found that the Oxford&nbsp;Covid-19 vaccine builds strong immunity to the virus.&nbsp;

Oxford coronavirus vaccine builds strong immunity, study finds

Study: Oxford vaccine builds strong immunity to Covid-19 New study on Oxford vaccine&nbsp;boosts global vaccination hope&nbsp; Vaccine front runner&nbsp;has entered Phase III clinical trials Study confirms vaccine successful in creating spike protein&nbsp; Vaccine induces strong immune response, study suggests

In a boost to global coronavirus vaccination hopes, a study has found that the Covid-19 vaccine spearheaded by Oxford University builds strong immunity to the virus. As the front-runner in the global race for a vaccine entered final Phase III clinical trials, researchers at Bristol University carried out tests to check whether it was behaving as intended. The Bristol team found that the vaccine was successfully able to instruct human cells to copy the genetic instructions to create the spike protein. The study confirmed that large amounts of the coronavirus spike protein are produced with great accuracy, and this goes a long way to explaining the success of the vaccine in inducing a strong immune response. Sarah Gilbert, who leads the Oxford University vaccine trial, praised the study for helping to explain the vaccine&rsquo;s effectiveness.

J&J kicks off final trial of single-shot Covid vaccine

Johnson &amp; Johnson has kicked off the final trial of a single-shot Covid-19 vaccine.&nbsp;If successful, the drug would simplify distribution of millions of doses

Johnson &amp; Johnson has kicked off the final trial of a single-shot Covid-19 vaccine. The company said that the vaccine will be tested on 60,000 people and it expects results of the Phase III trials by year-end or early next year. If successful, the drug would simplify distribution of millions of doses compared with leading rivals using two doses. Rival vaccines from Moderna, Pfizer and AstraZeneca all require two shots separated by several weeks, which make them much more difficult to administer. The company plans to manufacture as many as 1 billion doses in 2021

UAE to give under-trial Covid vaccine to health staff 

Amid a record spike in coronavirus cases, the UAE government has granted emergency approval for use of an under-trial coronavirus vaccine for health workers

The UAE government has granted emergency approval for use of an under-trial coronavirus vaccine for health workers. A phase III trial of a Covid-19 vaccine developed by a Chinese company began in the UAE in July and is yet to be completed. The govt announcement to give vaccine to the health staff has come amid a surge in coronavirus cases. The Arab country reported over 1,000 cases on Saturday, which is its highest since the start of the pandemic. There were close to 800 new cases on Monday. Emergency use of the vaccine, which is still being tested, was granted after a set criteria and after it had been tested on 31,000 volunteers, the govt said.

phase iii

Categories